Part 2- Advanced or Metastatic Gastric Cancer
1 clinical trials · Condition
◉ Watch Part 2- Advanced or Metastatic Gastric Cancer
| Record | Firm | Date |
|---|---|---|
| Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJ (NCT01791374) | Amgen | 2012-11-01 |
Track Part 2- Advanced or Metastatic Gastric Cancer automatically
Every clearance here is in the API, with alerts when new ones post.